Search Results - "Sahm, Felix"
-
1
Molecular alterations in meningioma: prognostic and therapeutic perspectives
Published in Current opinion in oncology (01-11-2020)“…PURPOSE OF REVIEWTo discuss recent advances in the meningioma biology and their clinical implications. RECENT FINDINGSMeningioma is the most common primary…”
Get full text
Journal Article -
2
DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology
Published in Neuro-oncology (Charlottesville, Va.) (02-11-2021)“…Abstract Recent years have witnessed a shift to more objective and biologically-driven methods for central nervous system (CNS) tumor classification. The 2016…”
Get full text
Journal Article -
3
EANO guideline on the diagnosis and management of meningiomas
Published in Neuro-oncology (Charlottesville, Va.) (02-11-2021)“…Abstract Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials have been conducted to guide clinical decision making,…”
Get full text
Journal Article -
4
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Published in Nature (London) (15-04-2021)“…Mutated isocitrate dehydrogenase 1 ( IDH1 ) defines a molecularly distinct subtype of diffuse glioma 1 – 3 . The most common IDH1 mutation in gliomas affects…”
Get full text
Journal Article -
5
cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading
Published in Brain pathology (Zurich, Switzerland) (01-07-2020)“…cIMPACT‐NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy) was established to evaluate and make practical recommendations…”
Get full text
Journal Article -
6
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
Published in Acta neuropathologica (01-08-2018)“…Recently, we described a machine learning approach for classification of central nervous system tumors based on the analysis of genome-wide DNA methylation…”
Get full text
Journal Article -
7
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
Published in Nature communications (12-02-2021)“…Both the perivascular niche (PVN) and the integration into multicellular networks by tumor microtubes (TMs) have been associated with progression and…”
Get full text
Journal Article -
8
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Published in JNCI : Journal of the National Cancer Institute (01-05-2016)“…The World Health Organization (WHO) classification and grading system attempts to predict the clinical course of meningiomas based on morphological parameters…”
Get full text
Journal Article -
9
Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging
Published in Radiology (01-09-2014)“…To compare multiparametric diagnostic performance with diffusion-weighted, dynamic susceptibility-weighted contrast material-enhanced perfusion-weighted, and…”
Get full text
Journal Article -
10
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
Published in Nature communications (18-02-2020)“…Intrinsic malignant brain tumors, such as glioblastomas are frequently resistant to immune checkpoint blockade (ICB) with few hypermutated glioblastomas…”
Get full text
Journal Article -
11
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO
Published in Acta neuropathologica (01-06-2015)“…The WHO 2007 classification of tumors of the CNS distinguishes between diffuse astrocytoma WHO grade II (A II WHO2007 ) and anaplastic astrocytoma WHO grade…”
Get full text
Journal Article -
12
Prognostic impact of genetic alterations and methylation classes in meningioma
Published in Brain pathology (Zurich, Switzerland) (01-03-2022)“…Meningiomas are classified based on histological features, but genetic and epigenetic features are emerging as relevant biomarkers for outcome prediction and…”
Get full text
Journal Article -
13
Tweety-Homolog 1 Drives Brain Colonization of Gliomas
Published in The Journal of neuroscience (19-07-2017)“…Early and progressive colonization of the healthy brain is one hallmark of diffuse gliomas, including glioblastomas. We recently discovered ultralong (>10 to…”
Get full text
Journal Article -
14
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Published in Neuro-oncology (Charlottesville, Va.) (30-01-2021)“…Abstract Background Malignant astrocytic gliomas in children show a remarkable biological and clinical diversity. Small in-frame insertions or missense…”
Get full text
Journal Article -
15
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
Published in Acta neuropathologica (01-06-2016)“…With the number of prognostic and predictive genetic markers in neuro-oncology steadily growing, the need for comprehensive molecular analysis of…”
Get full text
Journal Article -
16
Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology
Published in PloS one (19-01-2017)“…To correlate histopathologic findings from biopsy specimens with their corresponding location within enhancing areas, non-enhancing areas and necrotic areas on…”
Get full text
Journal Article -
17
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma
Published in Acta neuropathologica (01-10-2014)“…Astrocytoma and oligodendroglioma are histologically and genetically well-defined entities. The majority of astrocytomas harbor concurrent TP53 and ATRX…”
Get full text
Journal Article -
18
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
Published in Blood (20-09-2012)“…Langerhans cell histiocytosis (LCH) is a clinically and histologically heterogeneous disorder. Its classification as either reactive inflammatory or neoplastic…”
Get full text
Journal Article -
19
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
Published in Acta neuropathologica (01-04-2017)“…Mutations in codon 132 of isocitrate dehydrogenase ( IDH ) 1 are frequent in diffuse glioma, acute myeloid leukemia, chondrosarcoma and intrahepatic…”
Get full text
Journal Article -
20
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
Published in Oncotarget (28-02-2014)“…Indoleamine-2,3-dioxygenase (IDO) inhibitors have entered clinical trials based on their ability to restore anti-tumor immunity in preclinical studies…”
Get full text
Journal Article